In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fumarate, Bisoprolol Drug Master File in Korea (Fumarate, Bisoprolol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fumarate, Bisoprolol. The MFDS reviews the Fumarate, Bisoprolol KDMF as part of the drug registration process and uses the information provided in the Fumarate, Bisoprolol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fumarate, Bisoprolol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fumarate, Bisoprolol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Fumarate, Bisoprolol suppliers with KDMF on PharmaCompass.